JOBS Canadian Pharmaceutical Innovators Collaborating To Produce Monkeypox Vaccine
Tuesday, 09 August 2022 12:00.PM
St. Catharines-based sterile-fill injectable drug manufacturer Biolyse Pharma Corporation — has signed a memorandum of understanding with Montreal-based biopharmaceutical PnuVax Incorporated to mass-manufacture a key vaccine in the battle against monkeypox.
Currently, almost 1,000 cases of the monkeypox (MPXV) virus have been identified in Canada — the disease is painful, involving lesions and possible hospital visits. It is highly contagious and anyone can be at risk.
Together, the two companies have synergies to allow for an immediate scaling-up to produce millions of doses domestically, in the fight against monkeypox.
"We have Health Canada-licensed, Industrial Biosafety Level 2 manufacturing facilities, and all the equipment necessary to produce biologics for a monkeypox vaccine and the cGMP- fill and finishing capacity," said Brigitte Kiecken, President of Biolyse.
PnuVax CEO and co-founder Dr. Donald Gerson says: "In response to the emerging monkeypox outbreak, our team at PnuVax, in collaboration with Biolyse, is gearing-up to use our joint-capacity and expertise to help build the global supply of the monkeypox vaccine and reduce infections in Canada and abroad."
Kiecken adds: "Few in North America have the expertise of Dr. Gerson with monkeypox and related smallpox vaccines. He previously produced 350-million doses of the smallpox vaccine for the US national stockpile in the early 2000s, during a bioterrorism scare. We are lucky to have access to this expertise."
John Fulton, a pharmaceutical industry consultant and project partner at Biolyse, says: "As it stands, the Canadian federal government has been reticent about its monkeypox vaccine stockpile, with concerns in media accounts that it may be insufficient, as a global outbreak accelerates.
"This is a tremendous opportunity for these Canadian innovators and entrepreneurs to come together and contribute significantly to the global response," he said.
The monkeypox project could add up to 50 employees to each company.
SOURCE: BioNiagara
-
Related materials:
- 26-Jul-2024 10:22 AM 🧑🔎💵⚕️Supporting Canada's Health Workers by Improving Health Workforce Research, Planning and Data
- 26-Jul-2024 08:21 AM 🇨🇦🍁💵🧑🔎 Government Of Canada Helps Improve Women's Participation in The Mining Sector
- 25-Jul-2024 08:00 AM 🧑🔎 Student-Led Campaign Showcases Postgraduate College Education as Career Kick-Starter
- 24-Jul-2024 08:00 AM 🧑🔎💵Nonprofit Tech Workers Earn 33 Per Cent Less Than Tech Workers in Other Industries
- 23-Jul-2024 02:23 PM ONTARIO 🧑🔎💵Ontario Investing Up to $260 Million in New Funding to Train Workers
- 23-Jul-2024 10:22 AM ONTARIO 🧑🔎💵 Ontario Supporting Innovation in the Life Sciences 👨🔬🔬⚕️
- 21-Jul-2024 04:28 PM ONTARIO 🧑🔎 💵 Ontario Helping Insulation Workers Upgrade Skills and Land Jobs 🏗️
- 19-Jul-2024 04:52 PM ONTARIO 💵🧑🔎 Ontario Welcomes $358 Million Natural Gas Investment in Southwest Region 💨💰🔥
- 19-Jul-2024 08:00 AM ONTARIO 🧑🔎💵 Ontario Bolstering Nursing Workforce in Emergency Departments ⚕️
- 18-Jul-2024 12:00 PM 🇨🇦🍁💵 ONTARIO Governments Investing in Horticultural Research and Innovation 📰💻🔍